I think the answer is "Yes". Thus ENDP should now be an attractive takeover candidate with today's 33% haircut.
But the $26 seems reasonable, which is a 44% increase from the current $18 price. I'm long at $19.14, and I believe this selloff is way overdone based on price to cash flow..
P/E; HRTG = 5.10 vs. industry avg. of 20.90
Price/Sales 1.20 vs. 1.97
Price to Tangible Book 1.42 vs. 1.98
Price to Cash flow 5.10 vs. 20.00
Price to free cash flow 1.90 vs. 23.40
Div. Yield 1.30% vs. 0.80%
I bought some today at $15.73.
mostly used to cover the audit firm's legal butt.
With the fantastic financial ratios I stated in a previous post, IPI is definitely a bargain.
Price to sales (TTM) = 0.43 vs industry avg of 1.69
Price to tangible book= 0.18 vs 5.03
Price to cash flow (TTM) = 1.9 vs 10.3
Price to free cash flow = 1.9 vs 204!
Quick ratio = 2.5 vs 1.0
LT Debt to Equity (MRQ) = 0.16 vs. 0.63
I will agree they need some cash in the short term; probably better to do so with debt then with the crushed price of the equity;
Looks like a good candidate for a buyout.
I'm long at $0.98
1)Please authorize a share buyback at these low prices.
2) Please prove that you think this down move is way overdone by doing some serious insider buying.
I thank you in advance.
the 20 minute average line is rising, and is crossing above the 50 minute line at $13.19 at 10:35 ET.
Time to buy ( I bought too early at $13.72 but I am still looking forward to a big return.
the fact that at 10:24 ET, on the 1 minute chart, CYH closed above the 20 minute average for the first time during the day-only session. Then at 10:27 ET, CYH closed above the 50 minute average for the first time during the day session. When those two signals occur, the low is in, most of the time.
I'm long at $13.72
Good luck to longs, and my heart goes out to those who had to endure the earnings miss today. I think if you hang in there you will recoup today's losses eventually.
if they actually hit the midpoint of FY17 EPS of $3.60, and the industry average P/E = 19.10, then we can expect CYH's stock price to rise to $68.76 (= $3.60 x 19.10)
...which is the midpoint of the $700 high of las 12 months versus the $30 low.
He has a great track record. HRL already has fallen 1% since he made the bearish call.
So I sold some HRL short in the after hours
Price os stock now at $25.75
Lowered earnings expectation for the year = $1.87 (midpoint of range)
New P/E = 13.8 vs. industry average of 24.1
I plan to buy some shares after I determine that a bottom has been hit, through technical analysis.
She said that the results of the Lentiglobin gene therapy treatment that apparently worked great in 6 of the 9 particcipants were great and thus she is perplexed why the stock went down 20% today.
I'm long at $71.50
ESPR's P/B ratio = 2.90 vs. industry average of 20.37
Price to tangible book value = 0.96 vs industry avg of 8.34
Price to Sales = 0.36 vs 1.25 IA
Dividend yield = 3.20% vs 1.90% IA
Even before today's downmove, RMD was a bargain based on the following financial ratios:
1) P/E for RMD = 26.40 vs industry avg of 45.50; RMD is 42% underpriced.
2) Price/Tangible Book = 7.47 vs industry avg of 18.02; RMD is 56% underpriced.
3) Price/free cashflow = 65.70 vs industry avg of 132.60; RMD is 51% underpriced.
"In the mouth of 2 or 3 witness, let every word be established" The 3 witnesses above inplies that RMD will be making a 42% - 56% upmove sometime in the future.
I'm long at $56.21
Sounds like a good idea to me